tiprankstipranks
Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
US Market

Mersana Therapeutics (MRSN) Income Statement

Compare
526 Followers

Mersana Therapeutics Income Statement

Last quarter (Q3 2024), Mersana Therapeutics's total revenue was $12.60M, an increase of 63.65% from the same quarter last year. In Q3, Mersana Therapeutics's net income was $-11.50M. See Mersana Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 36.85M$ 26.58M$ 43.00K$ 828.00K$ 42.12M
Gross Profit
$ -111.41M$ 25.65M$ -131.97M$ -66.21M$ -12.92M
Operating Expenses
$ 36.85M$ 230.35M$ 168.90M$ 88.94M$ 72.32M
Depreciation and Amortization
$ 1.52M$ 927.00K$ 855.00K$ 1.01M$ 1.25M
EBITDA
$ -166.08M$ -199.96M$ -167.94M$ -86.68M$ -26.73M
Operating Income
$ -170.96M$ -204.69M$ -169.71M$ -87.69M$ -29.22M
Other Income/Expenses
$ -713.00K$ -445.00K$ -1.20M$ 65.00K$ 1.99M
Pretax Income
$ -171.67M$ -204.21M$ -170.06M$ -88.05M$ -28.21M
Net Income
$ -171.67M$ -207.54M$ -169.21M$ -88.40M$ -27.20M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.48$ -2.22$ -2.40$ -1.44$ -0.63
Diluted EPS
$ -1.48$ -2.22$ -2.40$ -1.44$ -0.63
Weighted Average Shares Outstanding
116.11M 93.65M 70.58M 61.49M 43.40M
Weighted Average Shares Outstanding (Diluted)
116.11M 93.65M 70.58M 61.49M 43.49M
Currency in USD

Mersana Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis